The vaccine’s EUA was expanded for use in children 12 to 15 years of age on May 10, 2021, “although limited scientific information is available,” per Pfizer.6 In subjects 12 to 15 years of age, the vaccine was 75%–100% effective over a two-month observation period.
PFIZER-BIONTECH COVID-19 VACCINE: Short-Term Efficacy & Safety Data by Physicians for Informed Consent
read more
